
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL

Intrinsic Value
The intrinsic value of one
MDGL
stock under the Base Case scenario is
465.74
USD.
Compared to the current market price of 342.44 USD,
Madrigal Pharmaceuticals Inc
is
Undervalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Madrigal Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Madrigal Pharmaceuticals Inc
Balance Sheet Decomposition
Madrigal Pharmaceuticals Inc
Current Assets | 1.1B |
Cash & Short-Term Investments | 998.6m |
Receivables | 30.5m |
Other Current Assets | 34.6m |
Non-Current Assets | 9.6m |
PP&E | 4.8m |
Intangibles | 4.8m |
Free Cash Flow Analysis
Madrigal Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Madrigal Pharmaceuticals Inc
Revenue
|
180.1m
USD
|
Cost of Revenue
|
-6.2m
USD
|
Gross Profit
|
173.9m
USD
|
Operating Expenses
|
-671.8m
USD
|
Operating Income
|
-497.9m
USD
|
Other Expenses
|
32m
USD
|
Net Income
|
-465.9m
USD
|
MDGL Profitability Score
Profitability Due Diligence
Madrigal Pharmaceuticals Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Score
Madrigal Pharmaceuticals Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
MDGL Solvency Score
Solvency Due Diligence
Madrigal Pharmaceuticals Inc's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Score
Madrigal Pharmaceuticals Inc's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
MDGL
is 414.73 USD
with a low forecast of 241.39 USD and a high forecast of 565.95 USD.
Dividends
Current shareholder yield for MDGL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MDGL
stock under the Base Case scenario is
465.74
USD.
Compared to the current market price of 342.44 USD,
Madrigal Pharmaceuticals Inc
is
Undervalued by 26%.